News
-
-
-
-
COMMUNIQUÉ DE PRESSE
CGTN AMERICA & CCTV UN: CMG Presents "Prelude to the Spring Festival Gala" in New York City, Celebrating the Year of the Horse
CGTN America & CCTV UN presents 'Prelude to the Spring Festival Gala' in New York City celebrating the Year of the Horse, showcasing cultural celebration, innovation, and global unity -
COMMUNIQUÉ DE PRESSE
SAUDI ARABIA ANNOUNCES 2026 FUTURE AVIATION FORUM TO CONVENE GLOBAL AVIATION LEADERS, EXTENDS RECORD-BREAKING AVIATION GROWTH
Saudi Arabia announces the 2026 Future Aviation Forum in Riyadh to gather global aviation leaders, highlighting record-breaking aviation growth. Registration open now -
COMMUNIQUÉ DE PRESSE
Verdera Energy Closes $20 Million Financing and Provides Update to Proposed Qualifying Transaction and Listing on the TSX-V
Verdera Energy Corp. and POCML 7 Inc. announce the closing of their $20 million offering. Verdera to trade on TSX-V under ticker symbol 'V'. Proceeds for project advancement and working capital -
COMMUNIQUÉ DE PRESSE
iGarden and French National Swimming Association Announce Exclusive Strategic Partnership and Reveal French Market Roadmap
iGarden and French National Swimming Association announce exclusive strategic partnership, unveiling French market roadmap at special event with French Olympic legends Alain Bernard and Fabien Gilot -
-
COMMUNIQUÉ DE PRESSE
GENFIT to receive US$20M milestone after Ipsen’s Iqirvo® exceeds the US$200M threshold in its first full year of net sales
GENFIT receives US$20M milestone from Ipsen as Iqirvo® surpasses US$200M net sales threshold in 2025. Phase 3 in PSC confirmed. CCA Phase 1b study progressing as planned. Financial position reinforced -
COMMUNIQUÉ DE PRESSE
GENFIT va recevoir un paiement d’étape de 20 M$ suite au dépassement du seuil des 200 M$ de ventes nettes d’Iqirvo® par Ipsen dès sa première année complète de commercialisation
GENFIT recevra un paiement d'étape de 20 M$ suite au dépassement des ventes nettes d'Iqirvo® par Ipsen, confirmant le lancement d'une Phase 3 dans la PSC et les progrès de l'étude de Phase 1b dans le CCA
